Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
D302525-5mg | 5mg | In stock | $9.90 | |
D302525-25mg | 25mg | In stock | $19.90 | |
D302525-100mg | 100mg | In stock | $44.90 | |
D302525-250mg | 250mg | In stock | $89.90 | |
D302525-500mg | 500mg | In stock | $159.90 | |
D302525-1g | 1g | In stock | $279.90 | |
D302525-5g | 5g | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $1,299.90 |
Iron chelator
Synonyms | Deferoxamine mesilate | Deferoxamine mesylate | Deferoxamine methanesulfonate | Desferrioxamine B mesylate |
---|---|
Specifications & Purity | ≥98% |
Biochemical and Physiological Mechanisms | Iron chelator. Blood-brain barrier permeable. Displays a number of biological actions such as immunomodulation, inhibition of inflammation and atherosclerosis, and reduction of neuronal death. |
Storage Temp | Store at -20°C,Argon charged |
Shipped In | Ice chest + Ice pads |
Action Type | CHELATING AGENT |
Mechanism of action | Iron chelating agent |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide;methanesulfonic acid |
---|---|
INCHI | InChI=1S/C25H48N6O8.CH4O3S/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26;1-5(2,3)4/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34);1H3,(H,2,3,4) |
InChi Key | IDDIJAWJANBQLJ-UHFFFAOYSA-N |
Canonical SMILES | CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O.CS(=O)(=O)O |
Isomeric SMILES | CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O.CS(=O)(=O)O |
PubChem CID | 62881 |
Molecular Weight | 656.79 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
G2408414 | Certificate of Analysis | Jun 29, 2024 | D302525 |
G2408420 | Certificate of Analysis | Jun 29, 2024 | D302525 |
G2408426 | Certificate of Analysis | Jun 29, 2024 | D302525 |
G2408427 | Certificate of Analysis | Jun 29, 2024 | D302525 |
G2408429 | Certificate of Analysis | Jun 29, 2024 | D302525 |
G2408430 | Certificate of Analysis | Jun 29, 2024 | D302525 |
G2408431 | Certificate of Analysis | Jun 29, 2024 | D302525 |
C2416210 | Certificate of Analysis | Mar 07, 2024 | D302525 |
C2416212 | Certificate of Analysis | Mar 07, 2024 | D302525 |
C2416208 | Certificate of Analysis | Mar 07, 2024 | D302525 |
C2416207 | Certificate of Analysis | Mar 07, 2024 | D302525 |
C2416206 | Certificate of Analysis | Mar 07, 2024 | D302525 |
C2416204 | Certificate of Analysis | Mar 07, 2024 | D302525 |
C2416202 | Certificate of Analysis | Mar 07, 2024 | D302525 |
J2331321 | Certificate of Analysis | Oct 21, 2023 | D302525 |
J2331320 | Certificate of Analysis | Oct 21, 2023 | D302525 |
J2331322 | Certificate of Analysis | Oct 21, 2023 | D302525 |
J2331415 | Certificate of Analysis | Oct 21, 2023 | D302525 |
J2331416 | Certificate of Analysis | Oct 21, 2023 | D302525 |
J2331417 | Certificate of Analysis | Oct 21, 2023 | D302525 |
J2331418 | Certificate of Analysis | Oct 21, 2023 | D302525 |
A2415184 | Certificate of Analysis | Oct 21, 2023 | D302525 |
L2322155 | Certificate of Analysis | Oct 21, 2023 | D302525 |
G2307279 | Certificate of Analysis | Jun 12, 2023 | D302525 |
I2306034 | Certificate of Analysis | Jun 12, 2023 | D302525 |
G2307276 | Certificate of Analysis | Jun 12, 2023 | D302525 |
G2307275 | Certificate of Analysis | Jun 12, 2023 | D302525 |
G2307274 | Certificate of Analysis | Jun 12, 2023 | D302525 |
G2307273 | Certificate of Analysis | Jun 12, 2023 | D302525 |
G2307272 | Certificate of Analysis | Jun 12, 2023 | D302525 |
G2307271 | Certificate of Analysis | Jun 12, 2023 | D302525 |
G2307301 | Certificate of Analysis | Jun 12, 2023 | D302525 |
G2307270 | Certificate of Analysis | Jun 12, 2023 | D302525 |
G2307269 | Certificate of Analysis | Jun 12, 2023 | D302525 |
B23101012 | Certificate of Analysis | Feb 01, 2023 | D302525 |
B2310542 | Certificate of Analysis | Feb 01, 2023 | D302525 |
B2310543 | Certificate of Analysis | Feb 01, 2023 | D302525 |
B2310544 | Certificate of Analysis | Feb 01, 2023 | D302525 |
B2310545 | Certificate of Analysis | Feb 01, 2023 | D302525 |
B2310546 | Certificate of Analysis | Feb 01, 2023 | D302525 |
D2318960 | Certificate of Analysis | Feb 01, 2023 | D302525 |
H2217345 | Certificate of Analysis | Aug 01, 2022 | D302525 |
H2217343 | Certificate of Analysis | Aug 01, 2022 | D302525 |
H2217342 | Certificate of Analysis | Aug 01, 2022 | D302525 |
H2217341 | Certificate of Analysis | Aug 01, 2022 | D302525 |
H2217340 | Certificate of Analysis | Aug 01, 2022 | D302525 |
H2217334 | Certificate of Analysis | Aug 01, 2022 | D302525 |
Sensitivity | Moisture sensitive、Air sensitive、Heat sensitive |
---|
Pictogram(s) | GHS08, GHS07 |
---|---|
Signal | Danger |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation H341:Suspected of causing genetic defects H317:May cause an allergic skin reaction H334:May cause allergy or asthma symptoms or breathing difficulties if inhaled |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P284:[In case of inadequate ventilation] Wear respiratory protection. P281:Use personal protective equipment as required. P271:Use only outdoors or in a well-ventilated area. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P272:Contaminated work clothing should not be allowed out of the workplace. P333+P313:IF SKIN irritation or rash occurs: Get medical advice/attention. P362+P364:Take off contaminated clothing and wash it before reuse. P203:Obtain, read and follow all safety instructions before use. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P318:if exposed or concerned, get medical advice. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. P319:Get medical help if you feel unwell. P342+P316:If experiencing respiratory symptoms: Get emergence medical help immediately. |
Starting at $37.90
1. Haoze Song, Jing Liang, Yuanyuan Guo, Yang Liu, Kuiru Sa, Guohong Yan, Wen Xu, Wei Xu, Lixia Chen, Hua Li. (2024) A potent GPX4 degrader to induce ferroptosis in HT1080 cells. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 265 (116110). [PMID:38194774] [10.1016/j.ejmech.2023.116110] |
2. Weimin Yin, Jiao Chang, Jiuyuan Sun, Yuge Zhao, Shiyu Chen, Hui Zhi, Jie Zang, Tingting Zhang, Yongyong Li, Haiqing Dong. (2024) Arginine nanoparticles mediated closed-loop ferroptosis enhancement for T cell activity boosting in cancer immunotherapy. Applied Materials Today, 36 (102047). [PMID:] [10.1016/j.apmt.2023.102047] |
3. Wang Shengmei, Guo Qiuyan, Xu Rubing, Lin Peng, Deng Guoyan, Xia Xinhua. (2023) Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma. JOURNAL OF NANOBIOTECHNOLOGY, 21 (1): (1-21). [PMID:37858186] [10.1186/s12951-023-02146-0] |
4. Shan Gao, Wanlin Zhang, Xingxing Zhai, Xue Zhao, Jianxin Wang, Jie Weng, Jianshu Li, Xingyu Chen. (2023) An antibacterial and proangiogenic double-layer drug-loaded microneedle patch for accelerating diabetic wound healing. Biomaterials Science, 11 (2): (533-541). [PMID:36472206] [10.1039/D2BM01588A] |
5. Kai Sun, Jiaying Yu, Jinzhong Hu, Jian Chen, Jia Song, Zhixin Chen, Zhuoer Cai, Zhuoxuan Lu, Liming Zhang, Zhifei Wang. (2022) Salicylic acid-based hypoxia-responsive chemodynamic nanomedicines boost antitumor immunotherapy by modulating immunosuppressive tumor microenvironment. Acta Biomaterialia, 148 (230). [PMID:35724919] [10.1016/j.actbio.2022.06.026] |
6. Xueyang Jin, Ming Zhang, Jinghui Lu, Ximeng Duan, Jinyao Chen, Yue Liu, Wenqiang Chang, Hongxiang Lou. (2021) Hinokitiol chelates intracellular iron to retard fungal growth by disturbing mitochondrial respiration. Journal of Advanced Research, 34 (65). [PMID:35024181] [10.1016/j.jare.2021.06.016] |
1. Furukawa T et al.. (2017) Chronic diazepam administration increases the expression of Lcn2 in the CNS.. Pharmacol Res Perspect, 5 (e00283). [PMID:28596835] |
2. Henning Y et al.. (2022) Hypoxia aggravates ferroptosis in RPE cells by promoting the Fenton reaction.. Cell Death Dis, 13 (7): (662). [PMID:35906211] |
3. Rakshit J et al.. (2020) Iron chelator Deferoxamine protects human neuroblastoma cell line SH-SY5Y from 6-Hydroxydopamine-induced apoptosis and autophagy dysfunction.. J Trace Elem Med Biol, 57 (126406). [PMID:31570251] |
4. Sias SR & Ingraham JL. (1979) Isolation and analysis of mutants of Pseudomonas aeruginosa unable to assimilate nitrate.. Arch Microbiol, 122 (3): (263-70). [PMID:120727] |
5. Yao Q et al.. (2018) Mesoporous silicate nanoparticles/3D nanofibrous scaffold-mediated dual-drug delivery for bone tissue engineering.. J Control Release, 279 (69-78). [PMID:29649529] |
6. Tadokoro T et al.. (2020) Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity.. JCI Insight, 5 (9): [PMID:32376803] |
7. You JH et al.. (2021) PGRMC1-dependent lipophagy promotes ferroptosis in paclitaxel-tolerant persister cancer cells.. J Exp Clin Cancer Res, 40 (350). [PMID:34749765] |
8. Fu C et al.. (2020) The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1a in liver cancer cells.. J Biol Chem, 295 (20): (7060-7074). [PMID:32277050] |
9. Nishimura K et al.. (2018) Type 3 iodothyronine deiodinase is expressed in human induced pluripotent stem cell derived cardiomyocytes.. Life Sci, 203 (276-281). [PMID:29684447] |
10. Sugiyama A et al.. (2020) xCT inhibitor sulfasalazine depletes paclitaxel-resistant tumor cells through ferroptosis in uterine serous carcinoma.. Oncol Lett, 20 (3): (2689-2700). [PMID:32782585] |
11. Haoze Song, Jing Liang, Yuanyuan Guo, Yang Liu, Kuiru Sa, Guohong Yan, Wen Xu, Wei Xu, Lixia Chen, Hua Li. (2024) A potent GPX4 degrader to induce ferroptosis in HT1080 cells. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 265 (116110). [PMID:38194774] [10.1016/j.ejmech.2023.116110] |
12. Weimin Yin, Jiao Chang, Jiuyuan Sun, Yuge Zhao, Shiyu Chen, Hui Zhi, Jie Zang, Tingting Zhang, Yongyong Li, Haiqing Dong. (2024) Arginine nanoparticles mediated closed-loop ferroptosis enhancement for T cell activity boosting in cancer immunotherapy. Applied Materials Today, 36 (102047). [PMID:] [10.1016/j.apmt.2023.102047] |
13. Wang Shengmei, Guo Qiuyan, Xu Rubing, Lin Peng, Deng Guoyan, Xia Xinhua. (2023) Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma. JOURNAL OF NANOBIOTECHNOLOGY, 21 (1): (1-21). [PMID:37858186] [10.1186/s12951-023-02146-0] |
14. Shan Gao, Wanlin Zhang, Xingxing Zhai, Xue Zhao, Jianxin Wang, Jie Weng, Jianshu Li, Xingyu Chen. (2023) An antibacterial and proangiogenic double-layer drug-loaded microneedle patch for accelerating diabetic wound healing. Biomaterials Science, 11 (2): (533-541). [PMID:36472206] [10.1039/D2BM01588A] |
15. Kai Sun, Jiaying Yu, Jinzhong Hu, Jian Chen, Jia Song, Zhixin Chen, Zhuoer Cai, Zhuoxuan Lu, Liming Zhang, Zhifei Wang. (2022) Salicylic acid-based hypoxia-responsive chemodynamic nanomedicines boost antitumor immunotherapy by modulating immunosuppressive tumor microenvironment. Acta Biomaterialia, 148 (230). [PMID:35724919] [10.1016/j.actbio.2022.06.026] |
16. Xueyang Jin, Ming Zhang, Jinghui Lu, Ximeng Duan, Jinyao Chen, Yue Liu, Wenqiang Chang, Hongxiang Lou. (2021) Hinokitiol chelates intracellular iron to retard fungal growth by disturbing mitochondrial respiration. Journal of Advanced Research, 34 (65). [PMID:35024181] [10.1016/j.jare.2021.06.016] |